McGill researchers launch intersex health communication guide

Researchers at McGill’s Centre of Genomics and Policy (CGP) have launched a first-of-its-kind guide to help Canadian health-care providers offer more inclusive, respectful and affirming care to intersex adults.

Biochemistry professor Ian Watson awarded Marathon of Hope Cancer Centres Network’s Data Sharing & Use Pilot program funding

Ian Watson, Member of the Goodman Cancer Institute and Associate Professor in the Department of Biochemistry has received funding from the Marathon of Hope Cancer Centres Network’s (MOHCCN)

New AI tool detects hidden warning signs of disease

McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in Nature Communications, the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

McGill researchers win Brain Canada’s Future Leaders in Canadian Brain Research Award

Jérôme Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.  

A transformation in neurosurgery

$10 million for Neuro-led project seeking new Alzheimer’s biomarkers

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

Availability of respite care almost triples a palliative care patient’s chance of dying at home

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

Scientists reveal how the brain uses objects to find direction

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

Physiology professor Claire M. Brown appointed inaugural Chair for Inclusion in Science and Engineering

Claire M. Brown, Professor in the Department of Physiology, has been selected as Chair for Inclusion in Science and Engineering (CISE) in the province of Quebec.

Biases hinder access to sexual assault evidence kits, study finds

Survivors of sexual assault in largely rural and remote Northwestern Ontario face systemic barriers when seeking forensic care, according to a new study led by McGill University researchers.

Sylvain Baillet inducted into the Royal Society of Canada

Sylvain Baillet, PhD, a global leader in brain imaging and systems neuroscience, has been inducted into the Royal Society of Canada, one of the nation’s highest academic honours.

Event | Seminar: Computer-based Predictions of RNA Structures: Where do we stand?

Join D2R for this hybrid seminar with Professor Eric Westhof from University of Strasbourg

Study linking depression to specific altered brain cells opens door to new treatments

Researchers at McGill University and the Douglas Institute have identified two specific types of brain cells that are altered in people with depression.

The study, published in Nature Genetics, opens the door to developing new treatments that target these cells and deepens our understanding of depression, a leading cause of disability worldwide that affects more than 264 million people.

Call for Letters of Intent: Translational Impact Research Program | Cycle 2

D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative’s strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.

Professor Simon Roy wins Marathon of Hope Clinician-Scientist Award for melanoma research

Simon Roy, Assistant Professor in the Department of Pathology, is one of four early-career clinician-scientists across Canada to receive the 2025 Clinician-Scientist Award from the Marathon of Hope Cancer Centres Network (MOHCCN).